Authors: Sun Yan, Sheng Xunlun, Zhou Jibo DOI: 10.3760/cma.j.cn115989-20221214-00586 Published 2024-07-10 Cite as Chin J Exp Ophthalmol, 2024, 42(7): 675-679. Abstract 【Download PDF】【Read Full Text】 Implantable collamer lens (ICL) is widely used because of its good effect of myopia correction.The change of ICL position […]
Category: Review
Preferred retinal locus and its clinical application
Authors: Li Shengnan, Zhang Jinglin, Wu Dezheng DOI: 10.3760/cma.j.cn115989-20210105-00011 Published 2024-07-10 Cite as Chin J Exp Ophthalmol, 2024, 42(7): 680-688. Abstract 【Download PDF】【Read Full Text】 Macular diseases usually lead to central vision loss, accompanied by a significant unstable fixation, resulting in disorders of fine vision, reading, and […]
Research progress on the application of XEN gel stent implantation in glaucoma treatment
Authors: Chen Yinqi, Yao Yihua, Zhu Yihua DOI: 10.3760/cma.j.cn115989-20220406-00140 Published 2024-06-10 Cite as Chin J Exp Ophthalmol, 2024, 42(6): 547-556. Abstract [Download PDF] [Read Full Text] XEN gel stent implantation, a novel minimally invasive glaucoma surgery (MIGS), constructs a novel subconjunctival […]
Advances in research on rodent models of glaucoma
Authors: Xie Zhi, Cao Ting, Zhang Xu DOI: 10.3760/cma.j.cn115989-20211026-00585 Published 2024-06-10 Cite as Chin J Exp Ophthalmol, 2024, 42(6): 557-563. Abstract [Download PDF] [Read Full Text] Glaucoma is a group of optic neuropathies characterized by the progressive loss of retinal ganglion cells […]
Research progress on the biomechanical properties of trabecular network in the pathogenesis of glaucoma
Authors: Bu Qianwen, Pan Xiaojing DOI: 10.3760/cma.j.cn115989-20210721-00421 Published 2024-06-10 Cite as Chin J Exp Ophthalmol, 2024, 42(6): 564-568. Abstract [Download PDF] [Read Full Text] Trabecular network, as the first resistance site of the aqueous humor outflow pathway, plays an important role in […]
Advances in methods to assess progression of glaucomatous visual impairment
Authors: Wu Qianru, Zhang Chun DOI: 10.3760/cma.j.cn115989-20200622-00447 Published 2024-06-10 Cite as Chin J Exp Ophthalmol, 2024, 42(6): 569-575. Abstract [Download PDF] [Read Full Text] Glaucoma is a group of ocular diseases characterized by structural damage to the optic nerve, and the goal […]
Systemic research update of minimally invasive glaucoma surgery
Authors: Wang Linyan, Ye Juan DOI: 10.3760/cma.j.cn115989-20210622-00366 Published 2024-06-10 Cite as Chin J Exp Ophthalmol, 2024, 42(6): 576-583. Abstract [Download PDF] [Read Full Text] Glaucoma is the leading cause of irreversible blindness worldwide.Conventional glaucoma surgeries have disadvantages like injuring the tissue […]
Research progress of gut microbiota in ophthalmic diseases
Authors: Shen Qianyi, Guan Huaijin, Ji Min DOI: 10.3760/cma.j.cn115989-20200120-00036 Published 2024-06-10 Cite as Chin J Exp Ophthalmol, 2024, 42(6): 584-586. Abstract [Download PDF] [Read Full Text] In recent years, research on gut microbiota has been increasing.Multiple studies have shown that the dysbiosis […]
Ocular manifestations of leukemia and ocular side effects of its treatments
Authors: Huang Zeyu, Chen Hui, Ji Min DOI: 10.3760/cma.j.cn115989-20201204-00822 Published 2024-06-10 Cite as Chin J Exp Ophthalmol, 2024, 42(6): 587-592. Abstract [Download PDF] [Read Full Text] Leukemia is a common malignancy of the hematologic system.Many patients may have ocular manifestations, and even […]
Research progress on regulation of Ang/Tie signaling pathway in the treatment of ocular neovascular diseases
Authors: Yang Jingyan, Wei Wenbin DOI: 10.3760/cma.j.cn115989-20220618-00283 Published 2024-05-10 Cite as Chin J Exp Ophthalmol, 2024, 42(5): 467-472. Abstract [Download PDF] [Read Full Text] The emergence of anti-vascular endothelial growth factor (VEGF) therapy has reduced the overall incidence of blindness from ocular […]